Atomoxetine's effect on societal costs in Sweden.

Objective: To compare societal costs between patients treated with atomoxetine and placebo in Sweden.

Method: Ninety-nine pediatric ADHD patients were randomized to a 10-week double-blind treatment with atomoxetine (n = 49) or placebo (n = 50). All parents received four sessions of psycho-education.